Table 2.
Serum | ||||
---|---|---|---|---|
No | Metabolite | Post Hoc Test p-Values | ||
C vs. PD | C vs. APDs | PD vs. APDs | ||
1 | C18:2 a | 0.049849 | NS | NS |
2 | Ornithine a | 0.045345 | NS | NS |
3 | Tyrosine b | 0.015431 | NS | NS |
4 | Putrescine b | 0.004395 | 0.011878 | NS |
5 | Spermidine a | 0.013458 | 0.000915 | NS |
6 | t4-OH-Proline b | 0.006106 | 0.00141 | NS |
7 | Total DMA a | NS | 0.001545 | NS |
8 | lysoPC a C28:0 b | NS | NS | 0.041845 |
9 | lysoPC a C28:1 b | 0.038853 | NS | NS |
10 | PC aa C34:4 a | NS | NS | 0.042019 |
11 | PC aa C38:1 a | NS | 0.008727 | NS |
12 | PC ae C36:4 a | NS | 0.00344 | NS |
13 | PC ae C38:4 a | NS | 0.046699 | NS |
14 | PC ae C38:5 a | NS | 0.007192 | NS |
a ANOVA; b Kruskal–Wallis; NS—not significant; C—control; PD—Parkinson’s disease; APDs—atypical parkinsonian disorders; DMA—dimethylarginine; C18:2—octadecadienylcarnitine; PC aa/ae C X:Y—diacyl(aa)/acyl-alkyl (ae) phosphatidylcholine with the total number of carbon atoms denoted by X and the number of double bonds indicated by Y.